RA Capital Management as of Dec. 31, 2011
Portfolio Holdings for RA Capital Management
RA Capital Management holds 25 positions in its portfolio as reported in the December 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sequenom | 16.4 | $27M | 6.1M | 4.45 | |
| Inhibitex | 12.9 | $21M | 2.0M | 10.94 | |
| ArthroCare Corporation | 8.1 | $14M | 427k | 31.68 | |
| Vanda Pharmaceuticals (VNDA) | 6.9 | $12M | 2.4M | 4.76 | |
| Endocyte | 5.9 | $9.8M | 2.6M | 3.76 | |
| Pozen | 5.8 | $9.6M | 2.4M | 3.95 | |
| OncoGenex Pharmaceuticals | 5.2 | $8.7M | 738k | 11.74 | |
| Columbia Laboratories | 5.1 | $8.5M | 3.4M | 2.50 | |
| Dyax | 5.1 | $8.4M | 6.2M | 1.36 | |
| Synageva Biopharma | 5.0 | $8.4M | 314k | 26.63 | |
| Derma Sciences | 4.8 | $7.9M | 1.0M | 7.58 | |
| INC Ventrus Biosciences | 4.2 | $7.0M | 870k | 8.01 | |
| ACADIA Pharmaceuticals (ACAD) | 3.4 | $5.7M | 5.3M | 1.08 | |
| Newlink Genetics Corporation | 2.1 | $3.5M | 500k | 7.04 | |
| Gentium S.p.A. | 1.8 | $3.0M | 487k | 6.08 | |
| Sangamo Biosciences (SGMO) | 1.5 | $2.5M | 866k | 2.84 | |
| Idenix Pharmaceuticals | 1.3 | $2.2M | 300k | 7.45 | |
| Dynavax Technologies Corporation | 1.3 | $2.2M | 650k | 3.32 | |
| MELA Sciences | 0.9 | $1.6M | 429k | 3.69 | |
| Novavax | 0.7 | $1.2M | 969k | 1.26 | |
| Repligen Corporation (RGEN) | 0.5 | $879k | 253k | 3.47 | |
| Uroplasty | 0.4 | $721k | 170k | 4.25 | |
| Targacept | 0.4 | $670k | 120k | 5.57 | |
| Discovery Laboratories | 0.1 | $219k | 131k | 1.68 | |
| Tearlab Corp | 0.1 | $201k | 180k | 1.12 |
